| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > News and Society > Politics > Official - Becoming a US Citizen or Permanent Resident is Now More Expensive |
|
Top Articles - Official - Becoming a US Citizen or Permanent Resident is Now More Expensive
Beginning July 30, 2007, immigrants seeking to become US citizens or permanent resi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product dents will have to pay more in immigration fees. In some cases, the fees have almos ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t tripled, such as the adjustment of status fee that will change from $325 to $930. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. Back in February the U.S. Citizenship and Immigration Services had announced thei here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe r plan of increasing their fee structure to finance the modernization of the agency d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro . According to a USCIS press release: “USCIS expects that the revenue from the new ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc fee structure will lead to a 20 percent reduction in average application processin easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi times by the end of fiscal year 2009, and will cut processing times by the end of nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically fiscal year 2008 for four key application types: the I-90 (Renew / Replace Permanen and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t Resident Card), I-140 (Immigration Petition for Alien Worker), the I-485, and the ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi N-400 (Naturalization). These four application types represent one-third of all ap ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a plications filed.” Although the above may sound like good news in terms of process dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ing times, the new fees are a hard blow to thousands of immigrants who couldn’t eve cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin n afford paying the current fees. With the new fees, a family of two adults and tw tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen children filing for a green card will pay more than $3,000 in fees alone—add to th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel at the cost of the required medical examinations, photos, and attorney’s fees. Som ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e of the changes include: * Form I-130 (Family-based Petition): From $190 to y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products $355 * Form I-140 (Employment-based Petition): From $195 to $475 * Form . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de I-485 (Adjustment of Status): From $325 to $930 (adults); from $225 to $600 (child elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ren under 14) The complete list of fees is available at the USCIS Web site: tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Benefit of Publishing Articles on the Web
|